Cipla Ltd.

Cipla Ltd. produces and markets generic and branded pharmaceuticals, vaccines, APIs and specialty drugs across India, the US, South Africa and worldwide. Its portfolio covers cardiovascular, diabetes, oncology, HIV, respiratory, and biosimilars, driving global growth.

Headquarters: India (IND)

Website: Visit Site 🔗
Type: Corporation

Company Profile

Sector: Manufacturing
Industry: Pharmaceutical Manufacturing

Employees: 30,313
HQ: Mumbai

Unlock the full potential.

Get access to Relative P/E Ratio Valuation Histogram.

Upgrade

Traded Instruments

+ Add Instrument 1

Symbol	Name	Type	Exchange	Currency	ISIN	Status	Actions
CIPLA	Cipla Ltd. Cap: 1183.6B \| P/E: 21.8	EQUITY	NSI	INR	INE059A01026	Active	📈